← Back to Search

Dynamic Splinting

1 for Carpal Tunnel Syndrome

N/A
Waitlist Available
Led By Stacey H Berner, MD
Research Sponsored by Advanced Centers for Orthopaedic Surgery and Sports Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 60 days
Awards & highlights

Study Summary

The Purpose of this study is to examine the effect of using the Carpal Tunnel Dynasplint® System on patients diagnosed with CTS in a randomized, controlled, cross-over study.

Eligible Conditions
  • Carpal Tunnel Syndrome

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~60 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 60 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Nerve Conduction Test results
Secondary outcome measures
Change in score of Levine-Katz outcome survey

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: 1Experimental Treatment1 Intervention
Treatment with Dynasplint device
Group II: 2Active Control1 Intervention
Control group; does not receive conservative or surgical treatment.

Find a Location

Who is running the clinical trial?

Advanced Centers for Orthopaedic Surgery and Sports MedicineLead Sponsor
Dynasplint Systems, Inc.Industry Sponsor
14 Previous Clinical Trials
400 Total Patients Enrolled
Stacey H Berner, MDPrincipal InvestigatorAdvanced Centers for Orthopaedic Surgery and Sports Medicine

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~4 spots leftby May 2025